Ann: TGA clearnance to assist treatment of Pelvic Organ Prolapse, page-13

Ditto.

Siren4 - around 14 to 140. Just for the POP market. UI market is bigger.
Add minor markets, add burette. It becomes easier to perceive a 'sale' of the company at 20 cents per share or more. But that is why I'd prefer a licensing or partnering outcome, to take advantage of capturing full market share over time and hold shares worth over $2 paying a healthy annual dividend in an r&d company still inventing stuff.
At the end of the day I've got no idea what the best offer will be. It could be 5 mill cash and 5% royalty. Either way this sp is only going up.
(imo)